chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Lump post vaccine, dissipated.  Lump returned on 1/16/2021 with redness and very warm to the touch. Lasted 48 hours. Redness dissipated. Lump present skin is warm to the touch at vaccine site
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication information was provided No Treatment information was provided   This case was linked to MOD-2021-336904 (Patient Link).
Mother reported that the patient received her first dose of DTaP in February, 1999, and 48 hours later, she developed a "hypotonic reaction." The patient was seen by the pediatrician. Her symptoms resolved within 8 hours.
Pain in left shoulder joint - (not muscle), very limited range of motion in shoulder, not relieved by NSAIDS or ice for 48 hours. I suspect, due to location of the injection....too high, and my symptoms, the shot was injected into the bursa sac and not the deltoid muscle.
very tired.; low grade fever; Premature ventricular contractions; heart irregularities; Muscle aches; Joint aches; COVID arm; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (COVID arm), VENTRICULAR EXTRASYSTOLES (Premature ventricular contractions), HEART RATE ABNORMAL (heart irregularities), MYALGIA (Muscle aches) and ARTHRALGIA (Joint aches) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sulfonamide allergy. Concomitant products included BUPROPION and SERTRALINE HYDROCHLORIDE (ZOLOFT) for an unknown indication.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced PAIN IN EXTREMITY (COVID arm), MYALGIA (Muscle aches) and ARTHRALGIA (Joint aches). On 21-Mar-2021, the patient experienced VENTRICULAR EXTRASYSTOLES (Premature ventricular contractions), HEART RATE ABNORMAL (heart irregularities) and PYREXIA (low grade fever). On an unknown date, the patient experienced FATIGUE (very tired.). The patient was treated with Manual therapy (Accupunture) for Pain in extremity; Manual therapy (Accupunture) for Myalgia; Manual therapy (Accupunture) for Arthralgia and Manual therapy (Accupunture) for Fatigue. On 09-May-2021, VENTRICULAR EXTRASYSTOLES (Premature ventricular contractions), HEART RATE ABNORMAL (heart irregularities) and PYREXIA (low grade fever) had resolved. At the time of the report, PAIN IN EXTREMITY (COVID arm), MYALGIA (Muscle aches), ARTHRALGIA (Joint aches) and FATIGUE (very tired.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.     This case was linked to MOD-2021-118674 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Follow-up appended and contained no new information. On 24-Jul-2021: Follow-up received and contained significant information screenshots of blood tests ordered at lab for Arthritic-ANA,ASO,RF,LYME,CCP,ESR ,C-reactive protein (CRP), Comprehensive Metabolic Panel, Complete Blood Count, CK total, TSH ,FT4 on  02 APR 2021and 16 APR 2021.
pt devel wheals w/itching, swollen lips & mild SOB p/vax;
Tenderness; Arm pain; Fatigue; Nausea; Muscle pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), NAUSEA (Nausea), MYALGIA (Muscle pain), TENDERNESS (Tenderness) and HEADACHE (Headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 7/Apr/2021) for an unknown indication. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history).    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced FATIGUE (Fatigue), NAUSEA (Nausea), MYALGIA (Muscle pain), TENDERNESS (Tenderness), HEADACHE (Headache) and PAIN IN EXTREMITY (Arm pain). At the time of the report, FATIGUE (Fatigue), NAUSEA (Nausea), MYALGIA (Muscle pain), TENDERNESS (Tenderness), HEADACHE (Headache) and PAIN IN EXTREMITY (Arm pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were given No treatment information was provided
At 11:30 am, Patient returned to clinic with complaint of redness and heat on both cheeks with lightheadedness, general feeling of weakness. BP=170/90, O2 Sat= 100% room air, P=89, R= 24, T= 97.8F. Paramedics were called, arrived at 11:50 AM. Patient was taken to Hospital.  Per Patient, She was given Benadryl and was sent home the same day.
Next day post vax, the pt experienced large circumscribed erythematous wheal at the injection site. The wheal was 4 inches x 4 inches in diameter. The pt was instructed to use Benadryl and cold packs to site. It was noted that the swelling started to resolve after three days of onset.
He got his vaccine, he had a pain in his arm where he got the vaccine. He started the next morning with bleeding in his rectum, very dark blood. It continued for 12 days, then all of a sudden it stopped. It quit and then started again about 8 days ago, 5/16/22. It is dark in nature and not slowing up. What sent alarms on him is the news information that women are having bleeding after receiving the vaccines. He had a colonoscopy recently and there were no issues, and does not have to have one for 10 years now. He went to his doctor and informed her about it and she said for him to get a colonoscopy and just had one and he did not go and get another one. He is deeply concerned as this should not be happening to him.
Fever, aches and pain worse in lower back and hips.. hot sweats, then freezing. Lasting 24-36 hrs. After second shot
Immediate: from first day after 2nd dose of Pfizer mRNA vaccine: 10 weeks of debilitating fatigue.  Several months after: right ear nerves were inflamed or something, and was hyper-sensitive.  7-10 months later: burning femoral arteries in both thighs ; worse in right thigh  12 months later; Blood pressure running at 205/115; was almost sent to ER by my hyperbaric oxygen treatment center which I was using to try to heal from the long series of vaccine injury.  18 months later; respiratory illness for 10 weeks due to suppression of my immune system; I was bulletproof before this mRNA vaccine.  24 months later; sudden erectile dysfunction.  I have never had Covid.  The strategy of using genetic code to make previously healthy tissue spew out pathogenic spike proteins is fatally flawed. At a minimum it creates an autoimmune disease upon the 2nd injection, or on the first injection if the victim already had antibodies from a Covid infection. I plan to have blood testing done to check the distribution of my antibodies to see if my B cells have been damaged.
Patient received Hepatitis B vaccination 2 days ago then developed blistering and itching to site within 24hours. Three blisters noted, 2 intact and 1 open, mild inflammation noted.
Pain in arm from elbow to shoulder. Arm swollen and red (rash) on tricep.
The first day I got the vaccine, my arm became very sore about 4 hours afterward. It kept getting more sore until I fell asleep. I stretched and massaged it.  The next day (Sunday), I woke up to a small canker sore in the left side of my mouth behind my top lip. It is right by where my canine and lateral incisor intersect. I thought nothing of it since I do occasionally get canker sores. As the day went on, the pain increased. I also noticed that two more sores had appeared. One on my lower lip right below where the original one is, and on my gums near my throat, like right where the gums end and throat begins. All on the left side. I got the shot in the left arm.  They're all more painful than usual, but the first one is the worst and is the biggest one I've ever had. Normally if I get one (like once every other month) the canker sore is small, white, and hurts if I touch it. The one behind my top lip is causing my lip to be noticeably swollen when I open my mouth, and it's definitely left a crater. I can't brush my teeth near where it is because it feels like I'm ripping out my flesh.  In addition, a submandibular node feels weird. It's not quite painful, but it's definitely a weird sensation that is noticeable at all times. I started feeling it one day after the vaccine, and today (two days after) the feeling is much more pronounced.  I have not seen a doctor since it seems like others have had these side effects, and they went away after a couple days. I just wanted to provide more data since it's definitely not the most comfortable thing right now.
Provider mistakenly pulled J and J vial and gave a 0.3ml dose as a 3rd dose booster of a previous 2 dose Pfizer series.  No adverse reaction reported by the individual who received the incorrect dose and brand for the booster.
doesn't feel well; feels terrible/horrible; like the flu; fever; very fatigued; nauseated; arm is sore at injection site; body aches almost like the flu; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (doesn't feel well), FEELING ABNORMAL (feels terrible/horrible), INFLUENZA LIKE ILLNESS (like the flu), PYREXIA (fever) and FATIGUE (very fatigued) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, the patient experienced MALAISE (doesn't feel well), FEELING ABNORMAL (feels terrible/horrible), INFLUENZA LIKE ILLNESS (like the flu), PYREXIA (fever), FATIGUE (very fatigued), NAUSEA (nauseated), VACCINATION SITE PAIN (arm is sore at injection site) and MYALGIA (body aches almost like the flu). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at a dose of UNK dosage form. At the time of the report, MALAISE (doesn't feel well), FEELING ABNORMAL (feels terrible/horrible), INFLUENZA LIKE ILLNESS (like the flu), PYREXIA (fever), FATIGUE (very fatigued), NAUSEA (nauseated), VACCINATION SITE PAIN (arm is sore at injection site) and MYALGIA (body aches almost like the flu) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided   Most recent FOLLOW-UP information incorporated above includes: On 09-Jun-2021: Initial additional document received on 09-JUN-2021 contains no new information.
4 - 5 days after vaccine given reset of persistent myalgias right and left arms distally. No objective findings. (transient local reaction deltoid area resolved 3 - 4 days as expected)
chills, malaise, muscle aches, kidney pain, ear ringing, flu like symptoms.
rash in her whole body; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH (rash in her whole body) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033A21A) for COVID-19 vaccination.     The patient's past medical history included Acid reflux (esophageal) since an unknown date. Concomitant products included OMEPRAZOLE for Acid reflux (esophageal).    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced RASH (rash in her whole body). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, RASH (rash in her whole body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Email ID Updated This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Mar-2021 and was forwarded to Moderna on 05-Mar-2021.    This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH (rash in her whole body) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033A21A) for COVID-19 vaccination.     The patient's past medical history included Acid reflux (esophageal) since an unknown date. Concomitant products included OMEPRAZOLE for Acid reflux (esophageal).    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced RASH (rash in her whole body). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, RASH (rash in her whole body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Email ID Updated
Case number PHEH2014US025090, is an initial spontaneous report from a nurse received on 09 Dec 2014. This report refers to a 88-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 10 Nov 2014. The nurse reported that FLUVIRIN administered had 12 separate temperature excursions lasting for 30 minutes over a period of 34 days. The temperature excursion began on 16 Oct 2014 and the temperature was between 46 to 49 degree F during the excursion. No adverse event reported following this medication error.
Information has been received from a health professional concerning a child in kindergarten who was vaccinated with a dose of Varivax (Oak/Merck). On 06-FEB-2006 the patient experienced shingles. Unspecified medical attention was sought. No product quality complain was involved. No other information was provided. Additional information has been requested.
Information has been received from a physicians assistant concerning a 25 year old female who on 9/29/06 was vaccinated with a first dose of HPV vaccine. Concomitant suspect therapy initiated a few days prior included nitrofurantoin (Macrobid) for the treatment of a urinary tract infection (dose not reported). Other concomitant therapy included drospirenone + ethinyl Estradiol (Yasmin). On 9/20/06 the pt called the physicians office to state that she had developed hives. The physicians office referred her to the ER where she was placed on methylprednisolone (Medrol Dosepak). The pt was not hospitalized. On 10/2/06 the pt called the physicians office to report that her tongue was swelling and her throat was closing. The pt was immediately referred to the ER where she was given epinephrine (Epi Pen). The pt was not hospitalized. On 1/04/06 the pt recovered. Hives, tongue swelling and throat closing were considered to be disabling, immediately life threatening and other important medical events (OMIC). The physicians assistant reported that they were not sure if the reactions was to the HPV or the Macrobid. Additional information has been requested.
Not getting 2nd dose; Sensation in back of throat after the 1st dose; Throat started to swell ,Throat felt swollen after 1st dose; This spontaneous case was reported by a patient and describes the occurrence of OROPHARYNGEAL DISCOMFORT (Sensation in back of throat after the 1st dose), PHARYNGEAL SWELLING (Throat started to swell ,Throat felt swollen after 1st dose) and PRODUCT DOSE OMISSION ISSUE (Not getting 2nd dose) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002a21a) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced OROPHARYNGEAL DISCOMFORT (Sensation in back of throat after the 1st dose) and PHARYNGEAL SWELLING (Throat started to swell ,Throat felt swollen after 1st dose). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Not getting 2nd dose). On 09-Mar-2021, OROPHARYNGEAL DISCOMFORT (Sensation in back of throat after the 1st dose) and PHARYNGEAL SWELLING (Throat started to swell ,Throat felt swollen after 1st dose) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (Not getting 2nd dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant medication information was not provided.  treatment medication information was not provided.
More intense covid arm; Problems whit her knees that she attributed to osteoarthritis.; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION COMPLICATION (More intense covid arm) and OSTEOARTHRITIS (Problems whit her knees that she attributed to osteoarthritis.) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032H21A) for COVID-19 vaccination.     Concurrent medical conditions included COPD and Fibrillation atrial.    On 27-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (More intense covid arm) and OSTEOARTHRITIS (Problems whit her knees that she attributed to osteoarthritis.). At the time of the report, VACCINATION COMPLICATION (More intense covid arm) and OSTEOARTHRITIS (Problems whit her knees that she attributed to osteoarthritis.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment reported   This case was linked to MOD-2022-439744, MOD-2021-018093 (Patient Link).
There was no adverse event, patient was vaccinated with a BUD vaccine as per moderna no need for re-vaccination.
Patient woke up 3/28/03 with severe HA.  On 3/29, HA continues with joint pain and @0700 pressure in chest that radiated down left arm began fever and chills.  Continues on 3/30/03 with heart palpitations.  On 4/2/03, heaviness at vaccination site, slight HA, pressure in chest continues.  4/2/03 onset of lower back pain, advised patient to see PMD ASAP.
My son was feverish and tired after vaccine, loss of appetite. Then a couple days after vaccine he woke up with dark red ears. then later  a rash on the face. He received steroid cream, it got better in a few weeks, then it came back again and again.  It has been nonstop with rashes on face and body now since he received this vaccine. He never had any issues like this until he received this HPV booster shot. Not sure if this vaccine triggered something, like an allergic reaction but we are still dealing with episodes 3 months later. We treated with primary dr, dermatalogist, allergist, and then had to go to ER recently and admitted for one day. Will be following up with allergist again.
This spontaneous report as received from a medical assistant refers to a 4 month old patient of unknown gender. The patient's concurrent conditions, medical history, concomitant medications, drug reactions and allergies were not reported. On 28-SEP-2018, the patient was vaccinated with improperly stored dose of ROTATEQ 2 ml tube, orally (lot # N022015, expiry date: 10-MAR-2019) for prophylaxis. The vaccine was exposed to the temperature of 32.21 degree Fahrenheit (°F) (32F to 35 F) and time frame was 3.5 hours from 06-SEP-2018. Previous excursion was 50.37°F for 4.5 hours as recorded by a data logger. No adverse effect was reported. No product quality complaint was involved. This is one of the several reports received from the same reporter source. Sender's Comments: US-009507513-1809USA002868: Original Case: 1809USA002868; US-009507513-1902USA009324: Original Case: 1902USA009323; US-009507513-1902USA009323: Original Case: 1902USA009323; US-009507513-1902USA009326: Original Case: 1902USA009323.
This spontaneous report as received from a registered nurse refers to a currently 4 year old patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 03-APR-2018, a 11 minute temperature excursion of -13.3 degrees Celsius occurred as advised by the nurse. On 11-MAY-2018, the patient was vaccinated with an improperly stored dose of PROQUAD recombinant Human albumin (rHA) or human serum albumin (HSA) of lot # N015623 with an expiry date of 15-NOV-2018 (Strength, frequency, route and anatomical location were not reported) for prophylaxis. All other temperatures were in range and average temperatures remained stable. The vaccine was in the freezer at the time of excursion (Product storage error). The nurse advised that this was a "supported temperature excursion" since it was between -10 and -14 (Units unspecified) for a period of 11 minutes and that the supply could remain in stock and was viable. No previous temperature excursion occurred. No adverse vaccine reactions were reported. The call was because of a data logger. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter.
Fluzone injection 11/1/07 - noted more discomfort at injection site than usual.  Left deltoid pain did not resolve - no redness or swelling noted.  Tender to palpation.  Tx: local ice packs, may use small lidocaine patch.
diaphoresis, tired/fatigue Narrative: Given juice, water, and a snack. Pt discharged without any other intervention.
Felt bad with a headcahe which kept getting worse; Fever that never got over 102F; Rash; Nausea; Vomiting; This is a spontaneous report from a contactable consumer (patient). A 76-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: not reported), via an unspecified route of administration on 15Jan2021 at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On a unspecified date, it was reported that the first 2-3 days the patient felt bad with a headache which kept getting worse, fever that never got over 102F. The headache was the worst which lasted 10 days or longer. This continued for about a week. The patient also had a rash which eventually disappeared, nausea & vomiting. The patient's doctor is not sure whether or not to continue with the second dose. Seeking guidance given the side effects experienced. The patient was tested for COVID-19 and the results were negative on an unspecified date. The outcome of the event rash was recovered while for the rest of the events was unknown.   Information about lot/batch number has been requested.
As described by mother: client c/o dizziness, eyes rolled back and body made jerking movement. States: looked spaced-out for approx. 1 min. Client had no memory of above. Also c/o blurred vision.